Previous studies have demonstrated that the berberine treatment of GBM cells can downregulate the activation of EGFR/MEK/ERK1/2 signaling, thus suggesting a potential role for ERK1/2 signaling in the present autophagy-dependent system [31, 32]. Here, MAPK3 is linked to glioblastoma.